Abstract
The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complex lipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
H.B. Brewer, Jr., Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins, Klin. Wochenschr. 59: 1023 (1981).
E.J. Schaefer and R.I. Levy, Pathogenesis and management of lipoprotein disorders, N. Engl. J. Med. 312: 1300 (1985).
D.S. Fredrickson, R.I. Levy, and R.S. Lees, Fat transport in lipoproteins: an integrated approach to mechanism and disorders, N. Engl. J. Med. 276: 32,94,148,215,273 (1967).
J.C. Osborne, Jr. and H.B. Brewer, Jr., The plasma lipoproteins, Adv. Protein Chem. 31: 253 (1977).
P. Alaupovic, D.M. Lee, and W.J. McConathy, Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins, Biochim. Biophys. Acta 260: 689 (1972).
D. Seidel, P. Alaupovic, and R.H. Furman, A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J. Clin. Invest. 48: 1211 (1969).
G. Kostner and P. Alaupovic, Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma, Biochemistry 11: 3419 (1972).
E. Pearlstein and F. Aladjem, Subpopulations of human serum very low density lipoproteins, Biochemistry 11: 2553 (1972).
J.J. Albers, C.-H. Chen, and F. Aladjem, Human serum lipoproteins. Evidence for three classes of lipoproteins in Sf 0-2, Biochemistry 11: 57 (1972).
P. Alaupovic, The concepts, classification systems, and nomenclature of human plasma lipoproteins, in “CRC Handbook of Electrophoresis. Lipoproteins: basic principles and concepts,” L.A. Lewis and J.J. Opplt, eds., CRC Press, Inc., Boca Raton, Florida, Vol. I (1980).
P. Alaupovic, The role of apolipoproteins in lipid transport processes, La Ricerca Clin. Lab. 12: 3 (1982).
G. Kostner, Isolation and characterization of lipoprotein B from high-density human serum lipoproteins, Biochem. J. 130: 913 (1972).
D.M. Lee and P. Alaupovic, Physicochemical properties of low-density lipoproteins of normal human plasma. Evidence for the occurrence of lipoprotein B in associated and free forms, Biochem. J. 137: 155 (1974).
R.F. Atmeh, J. Shepherd, and C.J. Packard, Subpopulations of apo-lipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy, Biochim. Biophys. Acta 751: 175 (1983).
W.J. McConathy, E. Koren, H. Wieland, E.M. Campos, D.M. Lee, H.U. Kloer, and P. Alaupovic, Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipo-protein B, J. Chromatogr. 342: 47 (1985).
J.C. Gibson, A. Rubinstein, N. Ngai, H.N. Ginsberg, N.-A. Le, R.E. Gordon, I.J. Goldberg, and W.V. Brown, Immunoaffinity isolation of apolipoprotein E-containing lipoproteins, Biochim. Biophys. Acta 835: 113 (1985).
Lipid Research Clinics Laboratory Manual 1, DHEW No. (NIH) 75-628, National Heart and Lung Institute, Bethesda, MD, 1974.
P. Alaupovic, C.-S. Wang, W.J. McConathy, D. Weiser, and D. Downs, Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product, Arch. Biochem. Biophys. 244: 226 (1986).
J.L. Goldstein and M.S. Brown, Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia, J. Biol. Chem. 249: 5153 (1974).
S.M. Grundy, Pathogenesis of hyperlipoproteinemia, J. Lipid Res. 25: 1611 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Alaupovic, P., Tavella, M., Fesmire, J. (1987). Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias. In: Malmendier, C.L., Alaupovic, P. (eds) Lipoproteins and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 210. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1268-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1268-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1270-3
Online ISBN: 978-1-4684-1268-0
eBook Packages: Springer Book Archive